Reata Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
10 Stock Tips From The Street’s Best Analysts
Article By: TipRanks
Sunday, July 29, 2018 4:39 PM EDT
Using the updated stock screener from the generated results, these 10 stocks stood out. Bear in mind the analyst consensus is based on ratings from the last three months.
In this article: EW, MA, MPC, MPWR, AMZN, MU, EXAS, GOOGL, WIX, RETA
Five Biotech IPOs Lead The Way In 2016
Article By: Don Dion
Friday, November 25, 2016 10:33 AM EDT
While the IPO market was relatively weak in 2016 overall, biopharma IPOs excelled. We have been particularly impressed with AveXis, Clearside Biomedical, Protagonist Therapeutics, Reata Pharma, and bluebird bio.
In this article: BLUE, AVXS, RETA, PTGX, CLSD
We're Cautious On The Reata Pharmaceuticals IPO
Article By: Don Dion
Wednesday, May 25, 2016 9:26 AM EDT
Reata Pharmaceuticals will offer 4.0 million shares at an expected price range of $14 to $16. RETA filed for the IPO on January 4, 2016. We suggest investors consider caution.
In this article: RETA


Latest Tweets for $RETA

No tweets yet!